Media

Filter by Category

All Blogs Presentations Press Releases Publications Videos

Filter by Program

Filter by Publish Date

C-Path Leads Novel Transatlantic Drug Safety Effort

Companies receive go ahead from FDA and EMEA to use new improved tests when assessing safety of new drugs.

The Food and Drug Administration is poised to throw its support behind a powerful new method of predicting the safety of experimen

Variations of a gene that determines a person’s sensitivity to warfarin are important in determining the initial doses of th

A Tucson-based research institute says it is improving the safety of a widely used blood thinning drug.

Dr. Alastair J.J. Wood, drug development authority, frequent advisor to the Food and Drug Administration (FDA) and former Assistan

The Critical Path Institute today announced that Peter B. Corr, Ph.D., has joined its Board of Directors. Dr. Corr has more than 3

The Critical Path Institute (C-Path) and Ventana Medical Systems, Inc. (Ventana) (NASDAQ: VMSI) today released additional informat

The Critical Path Institute (C-Path) announced the receipt of a $4 million grant from the Agency for Healthcare Research and Quali

Thanks to C-Path’s role as an independent, neutral third party, it has been successful in bringing together scientists from